EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NanoSHP099‐Targeted SHP2 Inhibition Boosts Ly6C low Monocytes/Macrophages Differentiation to Accelerate Thrombolysis

Kejing Ying iD, Wanghao Xin iD, Yiming Xu, Dandan Lv, Huiqi Zhu, Yeping Li, Wangting Xu, Chao Yan, Yiqing Li, Hongqiang Cheng, Enguo Chen, Guofeng Ma und 2 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202308166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Kejing Ying und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital…. Hauptthemen laut MEDLINE: Monocytes, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐associated thrombus (TAT) accounts for a high proportion of venous thromboembolism. Traditional thrombolysis and anticoagulation methods are not effective due to various complications and contraindications, which can easily lead to patients dying from TAT rather than the tumor itself. These clinical issues demonstrate the need to research diverse pathways for adjuvant thrombolysis in antitumor therapy. Previously, the phenotypic and functional transformation of monocytes/macrophages is widely reported to be involved in intratribal collagen regulation. This study finds that myeloid deficiency of the oncogene SHP2 sensitizes Ly6C low monocyte/macrophage differentiation and can alleviate thrombus organization by increasing thrombolytic Matrix metalloproteinase (MMP) 2/9 activities. Moreover, pharmacologic inhibition by SHP099, examined in mouse lung metastatic tumor models, reduces tumor and thrombi burden in tumor metastatic lung tissues. Furthermore, SHP099 increases intrathrombus Ly6C low monocyte/macrophage infiltration and exhibits thrombolytic function at high concentrations. To improve the thrombolytic effect of SHP099, NanoSHP099 is constructed to achieve the specific delivery of SHP099. NanoSHP099 is identified to be simultaneously enriched in tumor and thrombus foci, exerting dual tumor‐suppression and thrombolysis effects. NanoSHP099 presents a superior thrombus dissolution effect than that of the same dosage of SHP099 because of the higher Ly6C low monocyte/macrophage proportion and MMP2/MMP9 collagenolytic activities in organized thrombi.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MonocytesThrombosisAnimalsMiceLeukocytesMacrophagesThrombolytic TherapyPiperidinesPyrimidinesProtein Tyrosine Phosphatase, Non-Receptor Type 11

Stichwörter der Autor:innen

LiposomesLy6Clow monocytes/macrophagesSHP099collagenolysisthrombolysis

Substanzen

SHP099PiperidinesPyrimidinesProtein Tyrosine Phosphatase, Non-Receptor Type 11

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China.
  • Department of Respiratory, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Pathology and Pathophysiology, and Department of Respiratory Medicine at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
  • Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.

ORCID-Profile: Kejing Ying, Wanghao Xin

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Ying, K., Xin, W., Xu, Y., Lv, D., Zhu, H., Li, Y., Xu, W., Yan, C., Li, Y., Cheng, H., Chen, E., Ma, G., Zhang, X., & Ke, Y. (2024). NanoSHP099‐Targeted SHP2 Inhibition Boosts Ly6C low Monocytes/Macrophages Differentiation to Accelerate Thrombolysis. Advanced Science. https://doi.org/10.1002/advs.202308166

Vancouver

Ying K, Xin W, Xu Y, Lv D, Zhu H, Li Y, et al. NanoSHP099‐Targeted SHP2 Inhibition Boosts Ly6C low Monocytes/Macrophages Differentiation to Accelerate Thrombolysis. Advanced Science. 2024. doi:10.1002/advs.202308166

BibTeX
@article{Ying2024,
  author = {Ying, Kejing and Xin, Wanghao and Xu, Yiming and Lv, Dandan and Zhu, Huiqi and Li, Yeping and Xu, Wangting and Yan, Chao and Li, Yiqing and Cheng, Hongqiang and Chen, Enguo and Ma, Guofeng and Zhang, Xue and Ke, Yuehai},
  title = {NanoSHP099‐Targeted SHP2 Inhibition Boosts Ly6C low Monocytes/Macrophages Differentiation to Accelerate Thrombolysis},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308166}
}
Kostenlos starten →